Ledger. Australian venture funding, tracked

Company · Healthcare

Genetic Signatures

Develops PCR-based infectious disease tests under its EasyScreen brand

North Ryde, NSW

Investors

Every investor coverage indicates participated in a round Genetic Signatures raised.

Investor Rounds Invested
No investors recorded yet. Know one?

Something wrong? Tell us